Songqing Liu
- Topics
- Computational Drug Discovery Methods (3 papers)Pharmacovigilance and Adverse Drug Reactions (3 papers)Drug-Induced Adverse Reactions (2 papers)
- Journals
- European Journal of PharmacologyClinical Pharmacology & TherapeuticsFrontiers in Pharmacology
- Partner nations
- China
In The Last Decade
Songqing Liu
13 papers receiving 302 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Molecular Biology 137
- Pulmonary and Respiratory Medicine 62
- Cancer Research 57
- Oncology 36
- Pharmacology 32
Countries citing papers authored by Songqing Liu
This map shows the geographic impact of Songqing Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Songqing Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Songqing Liu more than expected).
Fields of papers citing papers by Songqing Liu
This network shows the impact of papers produced by Songqing Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Songqing Liu. The network helps show where Songqing Liu may publish in the future.
Co-authorship network of co-authors of Songqing Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Songqing Liu. A scholar is included among the top collaborators of Songqing Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Songqing Liu. Songqing Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 15 | |
| 6 | 15 | |
| 7 | 19 | |
| 8 | 6 | |
| 9 | Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activationbreakdown → | 118 |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 26 | |
| 13 | 77 | |
| 14 | 17 | |
| 15 | 3 |
About Songqing Liu
Songqing Liu is a scholar working on Toxicology, Pharmacology and Pharmacology, having authored 15 papers that have together received 304 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (3 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Drug-Induced Adverse Reactions (2 papers). The work is most often cited by research in Toxicology (28 citations), Biological Psychiatry (13 citations) and Biochemistry (23 citations). Songqing Liu has collaborated with scholars based in China. Frequent co-authors include Qian Du, Xiangru Zheng, Qinglong Liu, Wenjun Li, Yujie Lai, Lin Li, Wenjun Li, Xin Xi, Guili Huang and Jia Yang. Their work appears in journals such as European Journal of Pharmacology, Clinical Pharmacology & Therapeutics and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.